Abeona Therapeutics (ABEO) Change in Acquisitions & Divestments (2018 - 2026)

Abeona Therapeutics' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $24.9 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 54.11% year-over-year to $24.9 million in Q1 2026; TTM through Mar 2026 was $123.0 million, a 19.19% decrease from a year earlier, with the FY2025 full-year figure at $152.4 million, up 26.76% from the prior year.
• Change in Acquisitions & Divestments eased to $24.9 million in Q1 2026 per ABEO's latest filing, from $33.6 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $54.3 million in Q1 2025 and bottomed at $8.7 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $22.3 million (2024), against an average of $23.7 million.
• Across the five-year window, Change in Acquisitions & Divestments sank 65.32% in 2022 and soared 231.3% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $8.9 million in 2022, then jumped by 67.46% to $15.0 million in 2023, then surged by 100.22% to $30.0 million in 2024, then climbed by 12.08% to $33.6 million in 2025, then retreated by 25.87% to $24.9 million in 2026.
• Per Business Quant, the three latest ABEO Change in Acquisitions & Divestments figures stand at $24.9 million (Q1 2026), $33.6 million (Q4 2025), and $38.2 million (Q3 2025).